EUVIMEDEUVIMED entdecken
Crossref

Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation

Zhequan Fu, Qingyu Lin, Zhenwei Wang, Hongxing Su, Zhoumi Hu, He Zhang, Rong Sheng iD, Cheng Wang, Dengfeng Cheng iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.6c00276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Zhequan Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai200032, China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Fluorine Radioisotopes, Radiopharmaceuticals, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Nature Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noninvasive detection of microglia is crucial for monitoring their spatiotemporal dynamics and facilitating early medical intervention during the prodromal stages of these neuroinflammatory diseases. Colony-stimulating factor 1 receptor (CSF1R) is a promising imaging biomarker for microglia in neuroinflammation. However, currently developed CSF1R-targeted probes lack [18F]-labeled variants, and their stability, sensitivity, and specificity are all suboptimal to some extent. In our study, based on pyrrolopyrimidines(a distinct structure of CSF1R inhibitors), we developed the [18F]-labeled CSF1R-targeted probe-18F-FPPA (6-(4-(2-(2-(2-(fluoro-18F)ethoxy)ethoxy)ethoxy)phenyl)-N-methyl-N-(3-methylbenzyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine).18F-FPPA was synthesized with a radiochemical yield of 4–7%, molar activity of 30–70 GBq/μmol, and radiochemical purity exceeding 99%, which possesses excellent physicochemical properties, rapid blood pharmacokinetics (T1/2α = 2.50 min, T1/2β = 32.4 min), favorable invitro and in vivo stability, and a clear metabolic pathway via dual hepatobiliary and renal excretion. A marked uptake of 18F-FPPA was observed at the LPS injection site in the LPS group at 30–40 min postinjection. A decreased uptake also was observed in cold 19F-FPPA, BLZ945, and PLX3397 blocking groups (P < 0.05), and no obvious increase in the group of intraperitoneal injection of cyclosporine A (P > 0.05). The in vivo imaging and immunohistochemical results confirmed the specific uptake of 18F-FPPA by targeting CSF1R on microglia in inflamed tissues. Overall, our findings demonstrated that 18F-FPPA had great potential as a promising tracer for the imaging of neuroinflammatory diseases, while its unique binding profile also provides insights into CSF1R-targeted ligand development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyFluorine RadioisotopesRadiopharmaceuticalsNeuroinflammatory DiseasesReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAnimalsRatsLipopolysaccharidesMaleDisease Models, AnimalMicrogliaRats, Sprague-DawleyPyrimidinesInflammationTissue Distribution

Stichwörter der Autor:innen

CSF1 receptorLPS-induced rat modelMicrogliaPositron emission tomographyRadioligandneuroinflammation imaging

Substanzen

Fluorine RadioisotopesLipopolysaccharidesRadiopharmaceuticalsFluorine-18PyrimidinesReceptors, Granulocyte-Macrophage Colony-Stimulating Factor

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai200032, China.
  • Department of Nuclear Medicine, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai200030, China.
  • Department of Nuclear Medicine, Shanghai Clinical Research and Trial Center, Shanghai201210, China.
  • School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai201210, China.
  • State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang310058China.
  • Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai200127, China.

ORCID-Profile: Rong Sheng, Dengfeng Cheng

Förderung

  • National Nature Science Foundation of China

Zitieren

APA

Fu, Z., Lin, Q., Wang, Z., Su, H., Hu, Z., Zhang, H., Sheng, R., Wang, C., & Cheng, D. (2026). Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00276

Vancouver

Fu Z, Lin Q, Wang Z, Su H, Hu Z, Zhang H, et al. Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c00276

BibTeX
@article{Fu2026,
  author = {Fu, Zhequan and Lin, Qingyu and Wang, Zhenwei and Su, Hongxing and Hu, Zhoumi and Zhang, He and Sheng, Rong and Wang, Cheng and Cheng, Dengfeng},
  title = {Evaluation of 18F-FPPA as a Positron Emission Tomography Radioligand for Imaging CSF1R in LPS-Induced Rat Model of Neuroinflammation},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.6c00276}
}
Kostenlos starten →